BioWorld. Link to homepage.
BioWorld
BioWorld Science
BioWorld Asia
Data Snapshots
Biopharma
Medical technology
Infographics: Dynamic digital data analysis
Index insights
NME Digest
Special reports
Infographics: Dynamic digital data analysis
Trump administration impacts
Under threat: mRNA vaccine research
BioWorld at 35
Biopharma M&A scorecard
Bioworld 2025 review
BioWorld MedTech 2025 review
BioWorld Science 2025 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Coronavirus
More reports can be found here
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe
BioWorld - Saturday, February 14, 2026
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Dec. 1, 2017
View Archived Issues
CinRx closes Series B financing
Read More
Carrick initiates phase I program with CDK7 inhibitor CT-7001
Read More
Patient recruitment ongoing in phase I/II trial of PCM-075 in patients with AML
Read More
First-in-human phase I trial of AMG-701 enrolling patients with multiple myeloma
Read More
NIH and partners launch Imbokodo HIV vaccine trial
Read More
Orpheris announces the results of meeting with the FDA regarding regulatory path for OP-101
Read More
Cardiac Hsl gene knockdown provides model of hypoxia tolerance
Read More
MicroRNA-4639 a potential plasma biomarker of early Parkinson's disease
Read More
Phase I study of PGDM-1400 and PGT-121 mAbs in HIV-infected and HIV-uninfected adults
Read More
EMA validates application for Opdivo plus Yervoy in advanced renal cell carcinoma
Read More
Serum CETP may identify mortality risk in hemodialysis patients
Read More
Solid Biosciences initiates IGNITE DMD phase I/II study of SGT-001
Read More
Zhejiang Hisun Pharmaceutical presents new epothilone derivatives
Read More
Luoda Biosciences and Nanjing Shiqi Pharmaceutical describe novel anticancer compounds
Read More
FDA approves FoundationOne CDx diagnostic test
Read More
Novel AMP-activated protein kinase activators generated at Shionogi
Read More
Enanta patents novel farnesoid X receptor agonists
Read More
Mavupharma Series A financing to fund STING Modulators
Read More
FDA approves once-monthly Sublocade to treat opioid use disorder
Read More
FDA grants fast track to Armagen's AGT-181 for the treatment of patients with Hurler syndrome
Read More
Astellas Pharma exercises option to acquire Mitobridge
Read More
U.K.'s MHRA reclassifies Viagra for sale as non-prescription, pharmacy medicine
Read More
Astellas files for Japanese approval of Gonax 12-week formulation for prostate cancer
Read More
Afstyla launched in Japan for the treatment of hemophilia A
Read More
